共 241 条
[1]
Yanagisawa M(1988)A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411-415
[2]
Kurihara H(2016)Endothelin Pharmacol Rev 68 357-418
[3]
Kimura S(2002)International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature Pharmacol Rev 54 219-226
[4]
Tomobe Y(1991)Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor Circulation 83 469-475
[5]
Kobayashi M(2015)Vascular effects of endothelin receptor antagonists depends on their selectivity for ETA versus ETB receptors and on the functionality of endothelial ETB receptors J Cardiovasc Pharmacol 66 332-337
[6]
Mitsui Y(2016)Global overexpression of ET-1 decreases blood pressure—a systematic review and meta-analysis of ET-1 transgenic mice Kidney Blood Press Res 41 770-780
[7]
Yazaki Y(2004)Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction Circulation 110 2233-2240
[8]
Goto K(2015)Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade Proc Natl Acad Sci U S A 112 5141-5146
[9]
Masaki T(2005)Vascular endothelin in hypertension Vasc Pharmacol 43 19-29
[10]
Davenport AP(1996)Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension Hypertension (Dallas, Tex: 1979) 28 652-655